CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist? by Marie José Kersten, Maria Theresa Kuipers

Get full text

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia by Philipp B. Staber, Marie José Kersten, on behalf of the EHA Guidelines Committee

Get full text

Chimeric Antigen Receptor-T Cell Therapy by Jochen Buechner, Marie José Kersten, Miriam Fuchs, Florence Salmon, Ulrich Jäger

Get full text

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice? by Josée M. Zijlstra, Coreline N. Burggraaff, Marie José Kersten, Sally F. Barrington

Get full text

Dutch Physician’s Perspectives on Diagnosis and Treatment of Waldenström’s Macroglobulinemia Before and After the Implementation of a National Guideline by Karima Amaador, Marie José Kersten, Monique C. Minnema, Josephine M. I. Vos

Get full text

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment by Karima Amaador, Pythia T. Nieuwkerk, Monique C. Minnema, Marie José Kersten, Josephine M. I. Vos

Get full text

IgM monoclonal gammopathies of clinical significance: diagnosis and management by Jahanzaib Khwaja, Shirley D’Sa, Monique C. Minnema, Marie José Kersten, Ashutosh Wechalekar, Josephine M. Vos

Get full text

Precision medicine in diffuse large B-cell lymphoma: hitting the target by Joost S. Vermaat, Steven T. Pals, Anas Younes, Martin Dreyling, Massimo Federico, Igor Aurer, John Radford, Marie José Kersten

Get full text

Rare but Serious: Ibrutinib Induced Liver Failure by Fleur S. Kleijwegt, Afnan Abdul Roda, José Rolvink, Arnon P. Kater, Marie José Kersten, Josephine M.I. Vos

Get full text

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem by Esther Lutgens, Marie José Kersten, Tom T.P. Seijkens, Kikkie Poels, Suzanne I.M. Neppelenbroek, M. Louisa Antoni

Get full text

MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications by Ruben A.L. de Groen, Anne M.R. Schrader, Marie José Kersten, Steven T. Pals, Joost S.P. Vermaat

Get full text

Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the liter... by Marieke L. Nijland, Lianne Koens, Steven T. Pals, Ineke J.M. ten Berge, Frederike J. Bemelman, Marie José Kersten

Get full text

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG) by Igor Aurer, Martin Dreyling, Massimo Federico, Herve Tilly, Kim Linton, Eva Kimby, Martine E. D. Chamuleau, Marie Jose Kersten

Get full text

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia by Martin F.M. de Rooij, Annemieke Kuil, Willem Kraan, Marie José Kersten, Steven P. Treon, Steven T. Pals, Marcel Spaargaren

Get full text

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic by Martin Dreyling, Igor Aurer, Massimo Federico, Mats Jerkeman, Marie Jose Kersten, Kim Linton, Ulrich Mey, Herve Tilly, Christian Buske

Get full text

P1411: FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS by Milan Kos, Anne Mea Spanjaart, Liesbeth Van den Berg, Elise R.A. Pennings, Inger Nijhof, Linda Peute, Marie José Kersten, Martijn Van Oijen

Get full text

Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future by Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand, Carin A. Uyl-de Groot

Get full text

P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS by Carolien Maas, David van Klaveren, Mujde Durmaz, Otto Visser, Djamila Issa, Eduardus F.M. Posthuma, Josée Zijlstra, Martine Chamuleau, Pieternella Lugtenburg, Marie José Kersten, Avinash Dinmohamed

Get full text

P899: HOVON 104; LONG TERM FOLLOW-UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS by Monique Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Esther de Waal, Sonja Zweegman, Lidwien Tick, Annemiek Broijl, Stefan Schönland

Get full text

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin... by Anton Hagenbeek, Hans Mooij, Josée Zijlstra, Pieternella Lugtenburg, Gustaaf van Imhoff, Marcel Nijland, Sanne Tonino, Martin Hutchings, Marjolein Spiering, Roberto Liu, Harm van Tinteren, Marie José Kersten

Get full text